Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 1

Trial of Antibiotics Useful in Predicting TB in People with HIV, Study Finds
Using a trial of antibiotics may be useful for predicting tuberculosis in ambulatory patients with HIV, particularly in settings with limited access to resources, a new study suggests.
Why Do People With HIV Lose Smallpox Immunity Despite Vaccination?
Although antiretroviral therapy restores a patient with HIV’s immune system, lingering damage from HIV can render past vaccinations obsolete, a new study finds.
PrEP Users With Commercial Insurance Persist on Regimen Longer Than Medicaid-Insured Individuals
A new study conducted by CDC investigators found that commercially insured patients persisted on PrEP for median time of 13.7 months, compared to 6.8 months among Medicaid patients.
Targeting HIV
A new study demonstrates that some HIV "hotspots" transfer very few infections to nearby communities and instead receive more infections from outside.
Commentary Argues for Keeping TDF/FTC as First-Line PrEP
A new commentary argues that given the strong safety and efficacy profile of TDF/FTC, there is not sufficient benefit to warrant changing clinician emphasis to TAF/FTC.
Neural Tube Defect Prevalence Similar Between Infants Exposed to HIV and General Population
The prevalence of NTDs in pregnancies among women with diagnosed HIV infection was 7.0 per 10,000 live births, which was similar to that among the general population.
California's Plan to Improve PrEP Uptake A Model for Other States?: Public Health Watch
New legislation, cost assistance program will likely reduce transmission.
Are Pregnant Women Getting the Right HIV Antiretrovirals?
Roughly half of all American expectant mothers living with HIV are receiving treatments that don’t meet federal guidelines. A new study examines prescribing choices for this population.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?